Adverse circulatory effects of passive smoking during infancy: surprisingly strong, manifest early, easily avoided

G Cohen1, C Vardavas, E Patelarou

  • 1Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden.

Insights

Infants exposed to secondhand smoke show significantly altered blood pressure reactions (BPR) to stress. Reducing infant smoke exposure can prevent these adverse cardiovascular effects.

Area of Science:

  • Cardiovascular physiology
  • Pediatric health
  • Environmental health

Background:

  • Prenatal and early infancy exposure to tobacco smoke is a public health concern.
  • Understanding the cardiovascular impact of passive smoke exposure on infants is crucial.

Purpose of the Study:

  • To investigate the association between passive tobacco smoke exposure and blood pressure reactions (BPR) in infants.
  • To assess cardiovascular effects in infants exposed to environmental tobacco smoke.

Main Methods:

  • Observational field study comparing 4- to 6-month-old infants.
  • Groups included lifelong nonsmokers, passive smokers, and infants of active smokers.
  • Biochemical verification of smoke exposure (urine cotinine) and beat-to-beat blood pressure (BP) monitoring during stress maneuvers.

Main Results:

  • A significant difference in BPR was observed between control infants and passive smokers.
  • Infant BPR declined linearly with increasing infant cotinine levels, suggesting postnatal exposure is a key factor.
  • Infants of active smokers exhibited different BPR compared to passive smokers.

Conclusions:

  • Cardiovascular effects of passive smoking in newborns are pronounced and appear early.
  • Adverse effects can be mitigated by maintaining a smoke-free environment for infants.
  • Early intervention to reduce infant smoke exposure is vital for cardiovascular health.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
33
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K